Antiplatelet regimens following carotid artery revascularization

Am Heart J. 2022 Nov;253:48-52. doi: 10.1016/j.ahj.2022.07.004. Epub 2022 Jul 19.

Abstract

Dual antiplatelet therapy (DAPT) is indicated following carotid artery stenting (CAS) and single antiplatelet therapy (SAPT) following carotid endarterectomy (CEA), but it remains unknown how providers adhere to these guidelines in real-world clinical practice. Using the Vascular Quality Initiative New England data, we found that of 12,257 patients, 82% patients were discharged on DAPT following CAS and 66% were discharged on SAPT following CEA. While a high percentage of patients undergoing CAS appropriately receive DAPT, the use of SAPT following CEA exists with more variability and lower adherence rates.

Publication types

  • Letter

MeSH terms

  • Carotid Arteries
  • Carotid Stenosis* / surgery
  • Endarterectomy, Carotid*
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use
  • Retrospective Studies
  • Risk Factors
  • Stents
  • Stroke* / drug therapy
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors